Oxidation of Acetaminophen to Its Toxic Quinone Imine and Nontoxic Catechol Metabolites by Baculovirus-Expressed and Purified Human Cytochromes P450 2E1 and 2A6
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Acetaminophen (APAP), a widely used analgesic and antipyretic agent, is bioactivated by cytochromes P450 to cause severe hepatotoxicity. APAP is oxidized by two pathways to form a toxic intermediate, N-acetyl-p-benzoquinone imine (NAPQI), and a nontoxic catechol metabolite, 3-hydroxy-APAP (3-OH-APAP). We investigated the role of P450 2E1 and 2A6 in APAP oxidation by using baculovirus-expressed and highly purified forms of human P450 2E1 and 2A6. An electrochemical HPLC assay was developed to quantify both oxidative metabolites simultaneously. For the first time, it was demonstrated that human P450 2E1 selectively oxidized APAP to NAPQI (assayed as its glutathione conjugate, GS-APAP), whereas human P450 2A6 selectively oxidized APAP to 3-OH-APAP. At 1 mM APAP, the relative ratio for the formation of GS-APAP vs 3-OH-APAP with human P450 2E1 was approximately 6:1, whereas the ratio with human P450 2A6 was 1:3. Apparent Km and Vmax values for the formation of GS-APAP by human P450 2E1 were 1.3 mM and 6.9 nmol/min/nmol of P450, respectively, whereas they were 4.6 mM and 7.9 nmol/min/nmol of P450 for P450 2A6. Apparent Km and Vmax values for the formation of 3-OH-APAP by human P450 2E1 were 4.0 mM and 2.5 nmol/min/nmol of P450, respectively, whereas they were 2.2 mM and 14.2 nmol/min/nmol of P450, respectively, for P450 2A6. Thus, although at toxic doses of APAP P450 2E1 is the more efficient catalyst for the formation of the toxic metabolite NAPQI, P450 2A6 also can contribute significantly to NAPQI production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The remaining fraction, usually ranging from 5 to 15%, is oxidized by the CYP2E1, CYP1A2, CYP3A4, and CYP2A6 subfamilies of the P450 mixed-function oxidase system, resulting in the formation of N-acetyl-p-benzoquinoneimine (NAPQI) (50,62,159,211).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [50]
Citations
Cites
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781
Cytochrome P450: Structure, mechanism, and biochemistry
Pryor, W. A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)83807-x · Cited by 1,598
The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
Wrighton, S. A., & Stevens, J. C. (1992) · Critical Reviews in Toxicology · doi:10.3109/10408449209145319 · Cited by 944
Haining, R. L., Hunter, A. P., Veronese, M. E., Trager, W. F., & Rettie, A. E. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0414 · Cited by 249
Self-citationColes, B., Wilson, I., Wardman, P., Hinson, J. A., Nelson, S. D., & Ketterer, B. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90592-9 · Cited by 205
Self-citationHuman Cytochrome P450 2E1 Is a Major Autoantigen Associated with Halothane Hepatitis
Bourdi, M., Chen, W., Peter, R. M., Martin, J. L., Buters, J. T. M., Nelson, S. D., & Pohl, L. R. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960083q · Cited by 189
Self-citationNelson, S. D. (1995) · Drug Metabolism Reviews · doi:10.3109/03602539509029821 · Cited by 183
Self-citationInhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans
Zand, R., Nelson, S. D., Slattery, J. T., Thummel, K. E., Kalhorn, T. F., Adams, S. P., & Wright, J. M. (1993) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1993.125 · Cited by 153
Self-citationHolme, J. A., Dahlin, D. C., Nelson, S. D., & Dybing, E. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90232-6 · Cited by 127
Self-citationThe complex interaction between ethanol and acetaminophen*
Slattery, J. T., Nelson, S. D., & Thummel, K. E. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90050-8 · Cited by 99
Self-citation
Research works printed but not linked: 36
- Hinson J. A., 1980, Rev. Biochem. Toxicol., 12
- Nelson S. D., 1990, Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Disease 10, 267−278
- Vermeulen N. P. E., 1992, Drug Metab. Rev., 24
- Prescott, L. F. (1996)Paracetamol(Acetaminophen)aCriticalBibliographicReview, pp 285−351, Taylor & Francis Ltd., London.
- Mitchell J. R., 1973, J. Pharmacol. Exp. Ther., 187
- Potter W. Z., 1973, J. Pharmacol. Exp. Ther., 187
- Corcoran G. B., 1984, N-acetyl-p-benzoquinone imine. Mol. Pharmacol. 18, 536−542.
- Dahlin D. C., 1984, Proc. Natl. Acad. Sci. U.S.A. 81
- Hinson J. A., 1980, 3-Hydroxyacetaminophen: A microsomal metabolite of acetaminophen. Drug Metab. Dispos. 8, 289−294
- Forte A. J., 1984, The formation and toxicity of catechol metabolites of acetaminophen in mice. Drug Metab. Dispos. 12, 484−491
- Guengerich F. P., 1991, Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4, 168−179
- Raucy J. L., 1989, Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch. Biochem. Biophys. 271, 270−283
- Patten C. J., 1993, Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. 6, 511−518
- Lee S. S.-T., 1996, J. Biol. Chem., 271
- Burk R. F., 1990, Isoniazid potentiation of acetaminophen hepatotoxicity in the rat and 4-methylpyrazole inhibition of it. Res. Commun. Chem. Pathol. Pharmacol. 69, 115−118
- Guengerich, F. P. (1995) InCytochromeP450:Structure,Mechanism,andBiochemistry, 2nd ed. (Ortiz de Montellano, P. R., Ed.) Chapter 14, p 485, Plenum Press, New York.
- Yamano S., 1990, The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry 29, 1322−1329
- Yamazaki H., 1992, Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789−1794
- Duescher R. J., 1994, Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence for major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 342−349
- Zhou L., 1997, J. Pharmacol. Exp. Ther., 281
- Chen W., 1996, Baculovirus expression and purification of human and rat cytochrome P450 2E1. Arch. Biochem. Biophys. 335, 123−130
- Thompson S. J., 1997, Baculovirus mediated expression, purification, and catalytic activity of human CYP2A6. Toxicologist 36 (Abstract 109), 22
- Shen A. L., 1991, J. Biol. Chem., 266
- Thummel K. E., 1993, Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1. Drug Metab. Dispos. 21, 350−357
- Koenigs L. L., 1997, Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Drug Metab. Dispos. 25, 1407−1415
- Patten C. J., 1992, Catalytic properties of the human cytochrome P450 2E1 produced by cDNA expression in mammalian cells. Arch. Biochem. Biophys. 299, 163−171
- Peter R., 1990, Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol. 3, 566−573
- Wilkinson L., 1987, SYSTAT: The system for statistics
- Koop D. R., 1986, Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol. Pharmacol. 29, 399−404
- Levin W., 1986, N-Demethylation of N-nitrosodimethylamine catalyzed by purified rat hepatic microsomal cytochrome P-450: isozyme specificity and role of cytochrome b5. Arch. Biochem. Biophys. 248, 158−165
- Myers T. G., 1995, A comparative study of mouse liver proteins arylated by reactive metabolites of acetaminophen and its nonhepatotoxic regioisomer, 3‘-hydroxyacetanilide. Chem. Res. Toxicol. 8, 403−411
- Halmes N. C., 1996, ISSX Proc., 10, 76
- Rumack B. H., 1978, Acetaminophen overdose: Incidence, diagnosis and management in 416 patients. Pediatrics 62, 898−903
- Ramsay R. P., 1989, vitro effects of acetaminophen metabolites and analogues on the respiration of mouse liver mitochondria. Arch. Biochem. Biophys. 273, 449−457
- Myers T. G., 1994, J. Med. Chem., 37
- Abbreviations APAP, acetaminophen
Cited by
Items 201–250 of 250
Estudo do potencial farmacológico do óleo essencial das folhas da Eugenia uniflora L.
Victoria, F. N. (2013) · Americanae (AECID Library) · Cited by 2
Souto, R. S., Santos, A. M., Barros, W. R. P., & Lanza, M. R. V. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174664 · Cited by 1
Murashevych, B. V., Nichik, N. A., Zamyatina, A. K., Toropin, N. V., & Бурмистров, К. С. (2016) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428016050067 · Cited by 1
Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies
Barrett, J. S., & Zuppa, A. F. (2012) · Pharmacoepidemiology · doi:10.1002/9781119959946.ch2 · Cited by 1
Plewka, A., Plewka, D., Kowalówka-Zawieja, J., Przystanowicz, J., & Zielińska‐Psuja, B. (2012) · Medycyna Środowiskowa - Environmental Medicine · Cited by 1
Kalgutkar, A. S. S., Dalvie, D., Obach, R. S., & Smith, D. A. (2012) · Methods and principles in medicinal chemistry · doi:10.1002/9783527655748.ch4 · Cited by 1
Omoruyi, S. I., Enogieru, A. B., Momodu, O. I., Ayinde, B., & Grillo, B. (2015) · Nigerian Journal of Health Sciences · doi:10.67853/0s0qyc87 · Cited by 1
Larson, A. M. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch19 · Cited by 1
Drug‐Metabolizing Enzymes and Drug Toxicity
Li, A. P. (2021) · Wiley eBooks · doi:10.1002/9781119171003.ch4 · Cited by 1
Awasthi, N., Yadav, R., Shukla, A., & Kumar, D. (2021) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2021.108857 · Cited by 1
Borges, R. S., C, O. W. S., Holanda, L. H. C., Sousa, A. C. L. F., Vale, J. K. L., Alves, C. N., da Silva, A. B. F., & Gurrão, E. P. D. C. (2022) · Química Nova · doi:10.21577/0100-4042.20170927 · Cited by 1
Assessment of the Xenobiotics Toxicity Taking into Account Their Metabolism
Filimonov, D. A., Dmitriev, A. V., Rudik, A. V., & Poroikov, V. (2023) · Computational methods in engineering & the sciences · doi:10.1007/978-3-031-20730-3_2 · Cited by 1
O paracetamol mata? Hábitos de consumo na população portuguesa
Santos, D. B. D. A. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/0npf-n051 · Cited by 1
Cytochrome P450 family 4 enzymes in cancer: Leveraging bioactivation for therapeutic potential
Kowalski, J. P. (2020) · ResearchWorks at the University of Washington (University of Washington) · Cited by 1
Maruf, A. A., & O'Brien, P. J. (2015) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-19096-9_12 · Cited by 1
Oidovsambuu, S., Kang, K. S., Lee, S., Yun, J., Batsurén, D., Tunsag, J., & Nho, C. (2014) · Mongolian Journal of Chemistry · doi:10.5564/mjc.v14i0.190
Scimeca, M. S. (2005) · eCommons (Cornell University)
Tian, H. (2005) · D-Scholarship@Pitt (University of Pittsburgh)
Acetaminophen Hepatotoxicity and Cytokines.
Masubuchi, Y. (2001) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.16.151
Wahlin, M. D. (2014) · ResearchWorks at the University of Washington (University of Washington)
Investigation of Surface Interactions between Cytochrome b5 and Major Cytochrome P450 Isoforms
Zhao, C. (2012) · ResearchWorks at the University of Washington (University of Washington)
Fortschritte bei der Ras‐Inhibition aus medizinisch‐chemischer Perspektive
Sautier, B., Nising, C. F., & Wortmann, L. (2016) · Angewandte Chemie · doi:10.1002/ange.201608270
Kammoonah, S. (2016) · Summit (Simon Fraser University)
Charakterisierung der mikrosomalen Reduktion N-hydroxylierter Verbindungen
Kanzow, S. (2008) · MACAU: Open Access Repository of Kiel University
アセトアミノフェンによる Cytochrome P450 タンパク質の分解制御に関する研究
Santo, M. (2017) · Hiroshima University Institutional Repository
HIGH-THROUGHPUT METABOLISM-INDUCED TOXICITY ASSAYS ON A 384-PILLAR PLATE
Kang, S. (2018) · EngagedScholarship @ Cleveland State University (Cleveland State University)
Hrycay, E. G., & Bandiera, S. M. (2017) · Wiley eBooks · doi:10.1002/9780470921920.edm145
Enzymatic Transformation of Trace Organic Chemicals
Stadlmair, L. F. (2018) · mediaTUM (Technical University of Munich)
Atividades hepato e neuroprotetora do dietil-2-fenil-2-telurofenil vinilfosfonato
Ávila, D. S. (2009) · Americanae (AECID Library)
Artemísia absinthium minimiza a toxicidade induzida por paracetamol em camundongos
Franco, F. W. (2015) · Americanae (AECID Library)
Using Crystal Structures of Drug‐Metabolizing Enzymes in Mechanism‐Based Modeling for Drug Design
Sun, H., & Scott, D. O. (2020) · Wiley eBooks · doi:10.1002/9781118681121.ch24
Mucoactive agents in treating cough
Vranová, V., & Vašut, K. (2020) · Pediatrie pro praxi · doi:10.36290/ped.2020.070
Structural Alerts for Toxicity
Li, J. J. (2020) · Wiley eBooks · doi:10.1002/9781119607311.ch5
Wehr, A. Y. (2013) · Wiley eBooks · doi:10.1002/9781118541203.xen103
Dalvie, D., & Kalgutkar, A. S. S. (2023) · Medicinal Chemistry Research · doi:10.1007/s00044-023-03085-z
Mésźaros, P., Kovacs, S., & Almási, A. (2024) · Journal of Endocrinology and Metabolism · doi:10.14740/jem1001
Mechanisms of Acetaminophen Hepatotoxicity: Cell Death Signaling Mechanisms in Hepatocytes
Jaeschke, H., & Ramachandran, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00273-4
Gicquel, T., Pelletier, R., Gorrochategui, E., Heurté, M., Bouëdec, D. L., Chaker, J., Morel, I., Daré, B. L., & David, A. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.111727
Gallegos, E. M., Couvillion, K. E., & Simon, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34258-5.00004-9
Synthesis and characterization of silica-based nano-detoxifiers
Grötzl, L. (2024) · reposiTUm (TU Wien) · doi:10.34726/hss.2024.122261
Identification of extracellular miRNAs as biomarkers of liver fibrosis in a human 3D-culture system
Messner, C. J. (2021) · edoc (University of Basel) · doi:10.5451/unibas-ep83217
Potential drug interactions in warfarin users – an observational study focusing on pain medication
Hauta‐aho, M. (2023) · UTUPub (University of Turku)
Karthivashan, G. (2016) · Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia)
Kang, J. R., Lee, J., & Suh, H. N. (2026) · Journal of Veterinary Science · doi:10.4142/jvs.25260
Dixit, S., Deora, S., Nathawat, P., & Ganguly, M. (2026) · Nanoscale Advances · doi:10.1039/d6na00268d
Could NAPQI Contribute to Paracetamol Analgesia? Redox Modulation of Kv7 Ion Channels
M‐Alicante, S., Urrutia, J., Muguruza‐Montero, A., Revuelta, M., Arrizabalaga-Iriondo, A., Villarroel, Á., & Núñez, E. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70283
Jeffreys, L. N., Thistlethwaite, S., Cliff, M. J., Poddar, H., Bhanot, S., Tunnicliffe, R. B., Golovanova, M., Hollywood, K. A., Levy, C., Voice, M. W., et al. (2026) · ACS Omega · doi:10.1021/acsomega.6c01534
Wpływ cukrzycy na parametry farmakokinetyczne paracetamolu po podaniu dożylnym
(2010) · Wielkopolska Digital Library
Metadata
- Authors
- Chen, W., Koenigs, L. L., Thompson, S. J., Peter, R. M., Rettie, A. E., Trager, W. F., & Nelson, S. D.
- Affiliations
- University of Washington (US)
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 1998-02-27
- Volume
- 11
- Issue
- 4
- Pages
- 295-301
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W2050204181
- Cited by
- 226
- References
- 14
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 2 · 2023: 7 · 2022: 5 · 2021: 6 · 2020: 9 · 2019: 11 · 2018: 12 · 2017: 7 · 2016: 10 · 2015: 13 · 2014: 8 · 2013: 8 · 2012: 10
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Research in Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM049054, GM32165, P01GM032165, GM49054)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- paracetamol, N-acetyl-p-benzoquinone imine, CYP2E1, CYP2A6, hepatotoxicity, glutathione conjugates, enzyme kinetics, substrate specificity
- MeSH terms
- Acetaminophen, Aryl Hydrocarbon Hydroxylases, Cytochrome P-450 Enzyme System, Humans, Mixed Function Oxygenases, Baculoviridae, Analgesics, Non-Narcotic, Cytochrome P-450 CYP2E1, Cytochrome P-450 CYP2A6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.